Raymond James & Associates’s Research Frontiers REFR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,154
Closed -$29K 4185
2021
Q1
$29K Sell
10,154
-8,346
-45% -$32.4K ﹤0.01% 3895
2020
Q4
$52K Buy
18,500
+7,500
+68% +$21.2K ﹤0.01% 3624
2020
Q3
$30K Hold
11,000
﹤0.01% 3486
2020
Q2
$45K Hold
11,000
﹤0.01% 3386
2020
Q1
$26K Hold
11,000
﹤0.01% 3379
2019
Q4
$33K Hold
11,000
﹤0.01% 3583
2019
Q3
$35K Hold
11,000
﹤0.01% 3501
2019
Q2
$37K Hold
11,000
﹤0.01% 3526
2019
Q1
$24K Hold
11,000
﹤0.01% 3524
2018
Q4
$17K Hold
11,000
﹤0.01% 3447
2018
Q3
$17K Hold
11,000
﹤0.01% 3549
2018
Q2
$9K Sell
11,000
-16,500
-60% -$15K ﹤0.01% 3528
2018
Q1
$27K Hold
27,500
﹤0.01% 3367
2017
Q4
$29K Hold
27,500
﹤0.01% 3323
2017
Q3
$33K Hold
27,500
﹤0.01% 3271
2017
Q2
$35K Hold
27,500
﹤0.01% 3210
2017
Q1
$39K Hold
27,500
﹤0.01% 3161
2016
Q4
$50K Sell
27,500
-500
-2% -$1.03K ﹤0.01% 3095
2016
Q3
$73K Hold
28,000
﹤0.01% 3045
2016
Q2
$102K Buy
28,000
+7,000
+33% +$29.4K ﹤0.01% 2799
2016
Q1
$96K Buy
+21,000
New +$94.1K ﹤0.01% 2722

Other funds holding REFR

Raymond James & Associates's REFR Position: Q2 2021 in Review

Raymond James & Associates sold out of Research Frontiers (REFR) in Q2 2021, closing a stake of 10,154 shares — an estimated $29K sold.

Raymond James & Associates first reported a position in REFR in Q1 2016 and held it in 21 quarters. The position peaked at $102K in Q2 2016. 42 funds tracked by Wall St. Rank hold REFR as of Q2 2021.

  • Raymond James & Associates reported no remaining Research Frontiers position as of Q2 2021 after selling out during the quarter.
  • Raymond James & Associates sold 10,154 Research Frontiers shares in Q2 2021, an estimated $29K.
  • Raymond James & Associates first reported a position in Research Frontiers in Q1 2016 and held it in 21 quarters.
  • Raymond James & Associates's Research Frontiers position peaked at $102K in Q2 2016.
  • 42 funds tracked by Wall St. Rank held Research Frontiers as of Q2 2021.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.